Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production von Lynch, Lydia, Nowak, Michael, Varghese, Bindu, Clark, Justice, Hogan, Andrew E., Toxavidis, Vasillis, Balk, Steven P., O’Shea, Donal, O’Farrelly, Cliona, Exley, Mark A.

Volltext

Interplay between the immune system and adipose tissue in obesity von Exley, Mark A, Hand, Laura, O'Shea, Donal, Lynch, Lydia

Volltext

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy von Wolf, Benjamin J, Choi, Jiyoung Elizabeth, Exley, Mark A

Volltext

Exploiting CD1-restricted T cells for clinical benefit von Exley, Mark A., Dellabona, Paolo, Casorati, Giulia

Volltext

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial von Exley, Mark A, Friedlander, Phillip, Alatrakchi, Nadia, Vriend, Lianne, Yue, Simon, Sasada, Tetsuro, Zeng, Wanyong, Mizukami, Yo, Clark, Justice, Nemer, David, LeClair, Kenneth, Canning, Christine, Daley, Heather, Dranoff, Glenn, Giobbie-Hurder, Anita, Hodi, F Stephen, Ritz, Jerome, Balk, Steven P

Volltext

Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity von Boulenouar, Selma, Michelet, Xavier, Duquette, Danielle, Alvarez, David, Hogan, Andrew E., Dold, Christina, O’Connor, Donal, Stutte, Suzanne, Tavakkoli, Ali, Winters, Desmond, Exley, Mark A., O’Shea, Donal, Brenner, Michael B., von Andrian, Ulrich, Lynch, Lydia

Volltext

iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome von Fereidouni, Mohammad, Derakhshani, Afshin, Exley, Mark A.

Volltext

What Makes MAITs Wait? von Exley, Mark A.

Volltext

Broad applicability of the Goldspire™ platform for the treatment of solid tumors von Zilberberg, Jenny, Uhl, Christopher, Scott, Charles B., Andrews, David W., Exley, Mark A.

Volltext

Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy von Andrews, Carrie E., Zilberberg, Jenny, Perez-Olle, Raul, Exley, Mark A., Andrews, David W.

Volltext

Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy von Andrews, Carrie E., Zilberberg, Jenny, Perez-Olle, Raul, Exley, Mark A., Andrews, David W.

Volltext

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome von Hammond, Terese C., Purbhoo, Marco A., Kadel, Sapana, Ritz, Jerome, Nikiforow, Sarah, Daley, Heather, Shaw, Kit, van Besien, Koen, Gomez-Arteaga, Alexandra, Stevens, Don, Ortuzar, Waldo, Michelet, Xavier, Smith, Rachel, Moskowitz, Darrian, Masakayan, Reed, Yigit, Burcu, Boi, Shannon, Soh, Kah Teong, Chamberland, John, Song, Xin, Qin, Yu, Mishchenko, Ilya, Kirby, Maurice, Nasonenko, Valeriia, Buffa, Alexa, Buell, Jennifer S., Chand, Dhan, van Dijk, Marc, Stebbing, Justin, Exley, Mark A.

Volltext

Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma von Andrews, David W, Judy, Kevin D, Scott, Charles B, Garcia, Samantha, Harshyne, Larry A, Kenyon, Lawrence, Talekar, Kiran, Flanders, Adam, Atsina, Kofi-Buaku, Kim, Lyndon, Martinez, Nina, Shi, Wenyin, Werner-Wasik, Maria, Liu, Haisong, Prosniak, Mikhail, Curtis, Mark, Kean, Rhonda, Ye, Donald Y, Bongiorno, Emily, Sauma, Sami, Exley, Mark A, Pigott, Kara, Hooper, D Craig

Volltext

A2aR adenosine receptor controls cytokine production in iNKT cells von Nowak, Michael, Lynch, Lydia, Yue, Simon, Ohta, Akio, Sitkovsky, Michail, Balk, Steven P, Exley, Mark.A

Volltext

Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells von Mangan, Bozgana A, Dunne, Margaret R, O'Reilly, Vincent P, Dunne, Pádraic J, Exley, Mark A, O'Shea, Donal, Scotet, Emmanuel, Hogan, Andrew E, Doherty, Derek G

Volltext

Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human V delta 3 T Cells von Mangan, Bozgana A, Dunne, Margaret R, O'Reilly, Vincent P, Dunne, Padraic J, Exley, Mark A, O'Shea, Donal, Scotet, Emmanuel, Hogan, Andrew E, Doherty, Derek G

Volltext

Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin von Melum, Espen, Jiang, Xiaojun, Baker, Kristi D., Macedo, M. Fatima, Fritsch, Jürgen, Dowds, C. Marie, Wang, Jing, Pharo, Anne, Kaser, Arthur, Tan, Corey, Pereira, Catia S., Kelly, Samuel L., Duan, Jingjing, Karlsen, Tom H., Exley, Mark A., Schütze, Stefan, Zajonc, Dirk M., Merrill, Alfred H., Schuchman, Edward H., Zeissig, Sebastian, Blumberg, Richard S.

Volltext

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide von Nowak, Michael, Arredouani, Mohammed S, Tun-Kyi, Adrian, Schmidt-Wolf, Ingo, Sanda, Martin G, Balk, Steven P, Exley, Mark A

Volltext

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression von Stolk, Dorian, van der Vliet, Hans J, de Gruijl, Tanja D, van Kooyk, Yvette, Exley, Mark A

Volltext

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma von Cultrara, Christopher, Uhl, Christopher, Kirby, Kenneth, Abed Elrazaq, Essam, Zellander, Amelia, Andrews, David W, Scott, Charles B, Galluzzi, Lorenzo, Exley, Mark A, Zilberberg, Jenny

Volltext